£222 per delegate


Train your team

Are you interested in organising your own in-house training session? SLD Training can offer you all the necessary tools and guidance to deliver one of our courses at a location of your choice. Learn More.

Course Director

Nat is a practising GP and for over twenty years has held senior clinical leadership positions in primary and community care organisations providing treatment to those dependent upon alcohol or drugs. As a non-executive director of SLD Training, he oversees the delivery of the UK RCGP accredited courses in substance and alcohol misuse. Over the last 20 years almost 30,000 individuals have completed such courses and Nat has contributed to course development since inception. He is also the Primary Care Specialty Lead, for the UK National Institute for Health Research Clinical Research Network (Yorkshire and Humber) and he has contributed to over two hundred peer reviewed publications and invited conference presentations pertaining to treatment of addictions.

Dr Nat Wright
Non-executive Director
Certificate in the Management of Drug Misuse Update – Be Revalidation Ready  (RCGP Accredited)
Certificate in the Management of Drug Misuse Update – Be Revalidation Ready  (RCGP Accredited)
Course Dates
Start DateDurationLocationRemaining
There are currently no upcoming dates for this course

Training Dates
Please contact us for details on future course dates.

Course overview
This multi-disciplinary course is ideal for those working as part of a shared care scheme intending to provide treatment to drug users as part of a locally or nationally enhanced service.

The training day aims to improve participants’ understanding of the emerging evidence base and policy developments pertaining to drug related problems and equip participants with the skills and knowledge necessary to manage them.

Drug trends and drug policy are changing with an epidemic in novel psychoactive substances and we look at the increased emphasis upon recovery as we see a rising trend of drug-related deaths.

An ageing cohort of illicit drug users is present so we will look at new problems of co-morbidity and the unprecedented cost pressures placing an imperative on service reconfiguration to realise efficiency savings.

Learning outcomes

  • Will have discussed the increased purity and potency of illicit drugs, the changes in drug trends and those accessing services with more complex needs.
  • Will discuss the impact of the Covid-19 pandemic on the drug supply chains, increased street dealing and drug trafficking and developing innovative drug distribution models developing during lockdowns. We will also discuss European drug trends.
  • Will learn more about New Psychoactive Substances, their definition, categories, properties of the drugs, the dangers and complications and the scale of the problem along with the management of the acute and chronic effects of NPS.
  • Will be aware drug related death trends, including the general aging profile of drug users. Reducing the risk of drug related deaths with take home naloxone. Addressing the risk and other psychosocial interventions.
  • Will have explored non-opioid related deaths an other causes of mortality, like suicide, infectious diseases, homicide and digestive system disease.
  • We will learn more about prevalence and risk factors of previous DVT in community opioid using populations. Diagnosis, initial management and anticoagulant options.
  • We will learn more about hepatitis B & C, from its transmission, treatment indications and there effectiveness.
  • Will discuss the presentation of pain in drug users, the management of pain and prescription medication abuse and how poorly treated pain cam lead to prescription drug dependence.
  • Will have discussed a range of Trauma-focused care.
  • Will have completed through case study an assessment of need in relation to a complex drug using patient.
  • Will have discussed the benefits of working effectively with others in a multi-disciplinary context and discussed the roles of other professional disciplines such as pharmacy and nurse prescribers.
  • Will have discussed a range of Harm Reduction strategies.
  • Will have an increased awareness of the current policy context of recovery which underpins current drug treatment provision.
  • Will have discussed a range of equal opportunity issues related to the treatment of drug using patients in General Practice.

Course details

  • A full RCGP accredited training day.
  • 10 CPD hours will be gained on completion of this course.

Virtual delivery
Our virtual courses are designed to deliver an interactive and engaging experience through group discussions and collaborative polls via an online platform. If you are unable to travel to one of our National training events, you can receive high-quality accredited training without leaving your home.

Contact us

If you have a question or query regarding this course, check out our FAQ page. Couldn’t find what you were looking for? Fill out the enquiry form below and one of our course coordinators will be in touch with you shortly.

© 2022 SLD Training Ltd One Navigation Walk, Hebble Wharf, Wakefield WF1 5RH